ANDA 62305, held by Ross Labs. Erythromycin Ethylsuccinate.
As of Nov 16, 2026, ANDA 62305 (Pediamycin), held by Ross Labs, was not approved, with 0 approved supplements and 0 published complete response letters.
| PediamycinEQ 200MG BASE/5ML · granule;oral | Erythromycin Ethylsuccinate | Discontinued |
| PediamycinEQ 100MG BASE/2.5ML · suspension/drops;oral | Erythromycin Ethylsuccinate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters